Vildagliptin induced cutaneous leukocytoclastic vasculitis: A case report

Vildagliptin is a new generation theurapeutic agent of diabetes mellitus which belongs to dipeptidyl peptidase-IV inhibitor class acting via the incretin hormone system. It has moderate glycemic efficacy, a low propensity of causing hypoglycaemia and it is weight neutral. Overall, Dipeptidyl peptida...

Full description

Bibliographic Details
Main Authors: Serhat Sayin, Ethem Omeroglu, Semra Aslan Bilgin
Format: Article
Language:English
Published: Society of TURAZ AKADEMI 2018-03-01
Series:Medicine Science
Subjects:
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=265066